Charles Schwab’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.03M | Buy |
699,303
+76,163
| +12% | +$439K | ﹤0.01% | 2417 |
|
|
2025
Q1 | $4.11M | Sell |
623,140
-12,354
| -2% | -$81.5K | ﹤0.01% | 2352 |
|
|
2024
Q4 | $5.54M | Buy |
635,494
+10,542
| +2% | +$91.8K | ﹤0.01% | 2293 |
|
|
2024
Q3 | $12.2M | Buy |
624,952
+14,106
| +2% | +$276K | ﹤0.01% | 1938 |
|
|
2024
Q2 | $12.6M | Buy |
610,846
+12,122
| +2% | +$250K | ﹤0.01% | 1923 |
|
|
2024
Q1 | $12.8M | Buy |
598,724
+18,737
| +3% | +$400K | ﹤0.01% | 1862 |
|
|
2023
Q4 | $8.34M | Buy |
579,987
+16,566
| +3% | +$238K | ﹤0.01% | 2080 |
|
|
2023
Q3 | $5.14M | Buy |
563,421
+86,141
| +18% | +$786K | ﹤0.01% | 2242 |
|
|
2023
Q2 | $5.05M | Buy |
477,280
+6,289
| +1% | +$66.5K | ﹤0.01% | 2235 |
|
|
2023
Q1 | $5.76M | Buy |
470,991
+1,959
| +0.4% | +$24K | ﹤0.01% | 2134 |
|
|
2022
Q4 | $5.82M | Buy |
469,032
+17,679
| +4% | +$219K | ﹤0.01% | 2139 |
|
|
2022
Q3 | $6.17M | Sell |
451,353
-18,236
| -4% | -$249K | ﹤0.01% | 2107 |
|
|
2022
Q2 | $8.61M | Sell |
469,589
-8,328
| -2% | -$153K | ﹤0.01% | 1918 |
|
|
2022
Q1 | $7.69M | Buy |
477,917
+12,237
| +3% | +$197K | ﹤0.01% | 2079 |
|
|
2021
Q4 | $6.52M | Buy |
465,680
+11,190
| +2% | +$157K | ﹤0.01% | 2219 |
|
|
2021
Q3 | $8.51M | Buy |
454,490
+3,819
| +0.8% | +$71.5K | ﹤0.01% | 2096 |
|
|
2021
Q2 | $9.4M | Buy |
450,671
+7,444
| +2% | +$155K | ﹤0.01% | 2035 |
|
|
2021
Q1 | $12.5M | Buy |
443,227
+21,588
| +5% | +$610K | ﹤0.01% | 1826 |
|
|
2020
Q4 | $13.8M | Buy |
421,639
+61,621
| +17% | +$2.01M | 0.01% | 1662 |
|
|
2020
Q3 | $11M | Buy |
360,018
+30,689
| +9% | +$940K | 0.01% | 1629 |
|
|
2020
Q2 | $5.37M | Buy |
329,329
+76,668
| +30% | +$1.25M | ﹤0.01% | 1992 |
|
|
2020
Q1 | $2.51M | Buy |
252,661
+1,993
| +0.8% | +$19.8K | ﹤0.01% | 2178 |
|
|
2019
Q4 | $3.45M | Buy |
250,668
+6,640
| +3% | +$91.3K | ﹤0.01% | 2213 |
|
|
2019
Q3 | $3.7M | Buy |
244,028
+13,617
| +6% | +$207K | ﹤0.01% | 2131 |
|
|
2019
Q2 | $4.54M | Buy |
230,411
+6,380
| +3% | +$126K | ﹤0.01% | 2014 |
|
|
2019
Q1 | $3.72M | Buy |
224,031
+61,451
| +38% | +$1.02M | ﹤0.01% | 2123 |
|
|
2018
Q4 | $2.28M | Sell |
162,580
-2,144
| -1% | -$30.1K | ﹤0.01% | 2283 |
|
|
2018
Q3 | $2.88M | Buy |
164,724
+107,589
| +188% | +$1.88M | ﹤0.01% | 2299 |
|
|
2018
Q2 | $1.04M | Buy |
57,135
+11,961
| +26% | +$218K | ﹤0.01% | 2573 |
|
|
2018
Q1 | $848K | Buy |
45,174
+4,200
| +10% | +$78.8K | ﹤0.01% | 2568 |
|
|
2017
Q4 | $627K | Buy |
40,974
+1,774
| +5% | +$27.1K | ﹤0.01% | 2668 |
|
|
2017
Q3 | $587K | Buy |
39,200
+14,900
| +61% | +$223K | ﹤0.01% | 2669 |
|
|
2017
Q2 | $226K | Buy |
+24,300
| New | +$226K | ﹤0.01% | 2986 |
|